Loading...
Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?
Fingolimod 0.5-mg once-daily is an approved therapy for patients with relapsing–remitting multiple sclerosis (MS). Several pivotal and real-world studies have demonstrated that fingolimod is associated with the development of macular edema (ME). Herein, we present a case of a diabetic MS patient who...
Saved in:
| Published in: | Int J Mol Sci |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
MDPI
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5187906/ https://ncbi.nlm.nih.gov/pubmed/27983657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17122106 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|